 John Koo, MD
|
| Title | Professor of Clinical |
|---|
| School | UCSF School of Medicine |
|---|
| Department | Dermatology |
|---|
| Address | 515 Spruce Street
San Francisco CA 94143
|
|---|
| Phone | 415-476-4701 |
|---|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Asztalos ML, Heller MM, Lee ES, Koo J. The impact of emollients on phototherapy: A review. J Am Acad Dermatol. 2013 May; 68(5):817-24.
-
Ladizinski B, Heller MM, Bhutani T, Zitelli KB, Koo JY. Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy. J Drugs Dermatol. 2013 Feb 1; 12(2):e20-4.
-
Wong JW, Koo JY. Delusions of parasitosis. Indian J Dermatol. 2013 Jan; 58(1):49-52.
-
Wong JW, Nguyen TV, Koo JY. Primary psychiatric conditions: dermatitis artefacta, trichotillomania and neurotic excoriations. Indian J Dermatol. 2013 Jan; 58(1):44-8.
-
Park KK, Koo J. Use of psychotropic drugs in dermatology: Unique perspectives of a dermatologist and a psychiatrist. Clin Dermatol. 2013 Jan; 31(1):92-100.
-
Mutgi K, Koo J. Update on the role of systemic vitamin d in atopic dermatitis. Pediatr Dermatol. 2013 May; 30(3):303-7.
-
Kamangar F, Neuhaus IM, Koo JY. An evidence-based review of skin cancer rates on biologic therapies. J Dermatolog Treat. 2012 Aug; 23(4):305-15.
-
Wong JW, Davis SA, Feldman SR, Koo JY. Trends in older adult psoriasis outpatient health care practices in the United States. J Drugs Dermatol. 2012 Aug; 11(8):957-62.
-
Wong JW, Nguyen TV, Bhutani T, Koo JY. Treatment of psoriasis and long-term maintenance using 308 nm excimer laser, clobetasol spray, and calcitriol ointment: a case series. J Drugs Dermatol. 2012 Aug; 11(8):994-6.
-
Wong JW, Koo JY. The safety of systemic treatments that can be used for geriatric psoriasis patients: a review. Dermatol Res Pract. 2012; 2012:367475.
-
Wong JW, Kamangar F, Nguyen TV, Koo JY. Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm. Skin Therapy Lett. 2012 May; 17(5):6-9.
-
Heller MM, Wong JW, Nguyen TV, Lee ES, Bhutani T, Menter A, Koo JY. Quality-of-life instruments: evaluation of the impact of psoriasis on patients. Dermatol Clin. 2012 Apr; 30(2):281-91, ix.
-
Moscaliuc ML, Heller MM, Lee ES, Koo J. Goeckerman therapy: a very effective, yet often forgotten treatment for severe generalized psoriasis. J Dermatolog Treat. 2013 Feb; 24(1):34-7.
-
Lee ES, Heller MM, Kamangar F, Park KK, Koo JY. Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study. J Drugs Dermatol. 2012 Mar; 11(3):413-4.
-
Park KK, Murase JE, Koo J. Long-term prognosis of vitiligo patients on narrowband UVB phototherapy. J Am Acad Dermatol. 2012 Feb; 66(2):326-7.
-
Keaney TC, Bhutani T, Sivanesan P, Bandow GD, Weinstein SB, Cheung LC, Malick F, Koo J. Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis. J Am Acad Dermatol. 2012 Oct; 67(4):636-41.
-
Bhutani T, Koo J. A review of the chemopreventative effects of oral retinoids for internal neoplasms. J Drugs Dermatol. 2011 Nov; 10(11):1292-8.
-
Kannan S, Heller MM, Lee ES, Koo JY. The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know. J Dermatolog Treat. 2013 Apr; 24(2):148-52.
-
Muellenhoff MW, Koo JY. Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. J Dermatolog Treat. 2012 Aug; 23(4):290-304.
-
Heller MM, Murase JE, Koo JY. Practice gaps. Time and effort to establish therapeutic rapport with delusional patients: comment on "Delusional infestation, including delusions of parasitosis". Arch Dermatol. 2011 Sep; 147(9):1046.
-
Patel T, Bhutani T, Busse KL, Koo J. Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: a 6-week bilaterally controlled, investigator-blinded trial. Cutis. 2011 Sep; 88(3):149-54.
-
Dennis M, Bhutani T, Koo J, Liao W. Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy. J Dermatolog Treat. 2013 Feb; 24(1):2-6.
-
Bhutani T, Zitelli KB, Koo J. Yin-yang strategy: proposing a new, effective, repeatable, sequential therapy for psoriasis. J Drugs Dermatol. 2011 Aug; 10(8):831-4.
-
Haddican MM, Bhutani T, McClelland PB, Koo JY. Why are there significant differences in published narrowband ultraviolet B dosimetry recommendations? The need for national standardization of phototherapy treatment. J Am Acad Dermatol. 2011 Aug; 65(2):411-4.
-
Park KK, Kamangar F, Heller M, Lee E, Bhutani T, Busse K, Patel T, Koo J. Instant barrier repair: a pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis. J Dermatolog Treat. 2013 Apr; 24(2):119-21.
-
Heller MM, Lee ES, Koo JY. Stress as an influencing factor in psoriasis. Skin Therapy Lett. 2011 May; 16(5):1-4.
-
Busse K, Koo J. Introducing the delayed retinoid burn: a case report and discussion of this potential risk of retinoid-phototherapy combination management. J Am Acad Dermatol. 2011 May; 64(5):1011-2.
-
Haddican MM, Koo JY. Is tuberculin skin testing reliable during anti-tumor necrosis factor-alfa therapy? A case report and review of the literature. J Am Acad Dermatol. 2011 Jul; 65(1):195-7.
-
Hayes J, Koo J. Depression and acitretin: a true association or a class labeling? J Drugs Dermatol. 2011 Apr; 10(4):409-12.
-
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011 Jul; 65(1):137-74.
-
Gattu S, Busse K, Bhutani T, Chiang C, Nguyen T, Becker E, Koo JY. Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study. J Dermatolog Treat. 2012 Apr; 23(2):103-8.
-
Bhutani T, Koo J, Maibach HI. Efficacy of clobetasol spray: factors beyond patient compliance. J Dermatolog Treat. 2012 Feb; 23(1):11-5.
-
Ladizinski B, Busse KL, Bhutani T, Koo JY. Aripiprazole as a viable alternative for treating delusions of parasitosis. J Drugs Dermatol. 2010 Dec; 9(12):1531-2.
-
Pugashetti R, Lim HW, Koo J. Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options? J Dermatolog Treat. 2010 Nov; 21(6):326-30.
-
Gattu S, Becker EM, Koo JY. A rare case of non-Hodgkins B-cell lymphoma in a psoriatic patient: a case report and literature review. J Drugs Dermatol. 2010 Oct; 9(10):1277-81.
-
Zeichner JA, Lebwohl MG, Menter A, Bagel J, Del Rosso JQ, Elewski BE, Feldman SR, Kircik LH, Koo J, Gold LS, Tanghetti E. Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis. 2010 Sep; 86(3 Suppl):5-31; quiz 32.
-
Bhutani T, Koo J. Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series. J Dermatolog Treat. 2011 Apr; 22(2):75-8.
-
Pugashetti R, Koo J. Phototherapy in pediatric patients: choosing the appropriate treatment option. Semin Cutan Med Surg. 2010 Jun; 29(2):115-20.
-
Murase JE, Koo JY, Berger TG. Narrowband ultraviolet B phototherapy influences serum folate levels in patients with vitiligo. J Am Acad Dermatol. 2010 Apr; 62(4):710-1.
-
Hayes J, Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther. 2010 Mar-Apr; 23(2):174-80.
-
Braham SJ, Pugashetti R, Koo J, Maibach HI. Occlusive therapy in atopic dermatitis: overview. J Dermatolog Treat. 2010 Mar; 21(2):62-72.
-
Gattu S, Pang ML, Pugashetti R, Malick F, Hong J, Bowers E, Levatter JI, Koo J. Pilot evaluation of supra-erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis. J Dermatolog Treat. 2010 Jan; 21(1):54-60.
-
Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010 Jan; 62(1):114-35.
-
Feldman SR, Koo JY, Johnson LA, Preston NJ. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis. Cutis. 2009 Oct; 84(4 Suppl):25-32.
-
Sivanesan SP, Gattu S, Hong J, Chavez-Frazier A, Bandow GD, Malick F, Kricorian G, Koo J. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks. J Am Acad Dermatol. 2009 Nov; 61(5):793-8.
-
Lee CS, Koo J. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison. J Drugs Dermatol. 2009 Aug; 8(8):751-5.
-
Nguyen T, Gattu S, Pugashetti R, Koo J. Practice of phototherapy in the treatment of moderate-to-severe psoriasis. Curr Probl Dermatol. 2009; 38:59-78.
-
Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009 Sep; 61(3):451-85.
-
Nguyen TU, Koo J. Etanercept in the treatment of plaque psoriasis. Clin Cosmet Investig Dermatol. 2009; 2:77-84.
-
Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009 Apr; 60(4):643-59.
-
Pugashetti R, Koo J. Efalizumab discontinuation: a practical strategy. J Dermatolog Treat. 2009; 20(3):132-6.
-
Tuerk MJ, Koo J. A practical review and update on the management of pruritus sine materia. Cutis. 2008 Sep; 82(3):187-94.
-
Buell C, Koo J. Long-term safety of mycophenolate mofetil and cyclosporine: a review. J Drugs Dermatol. 2008 Aug; 7(8):741-8.
-
Pang ML, Murase JE, Koo J. An updated review of acitretin--a systemic retinoid for the treatment of psoriasis. Expert Opin Drug Metab Toxicol. 2008 Jul; 4(7):953-64.
-
Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008 May; 58(5):851-64.
-
Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May; 58(5):826-50.
-
Kircik L, Bagel J, Korman N, Menter A, Elmets CA, Koo J, Yang YC, Chiou CF, Dann F, Stevens SR. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. J Drugs Dermatol. 2008 Mar; 7(3):245-53.
-
Accordino RE, Engler D, Ginsburg IH, Koo J. Morgellons disease? Dermatol Ther. 2008 Jan-Feb; 21(1):8-12.
-
Koo J. Treatment of psychocutaneous diseases. Dermatol Ther. 2008 Jan-Feb; 21(1):1.
-
Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008 Jan-Feb; 21(1):54-9.
-
Malick F, Howard J, Koo J. Understanding the psychology of the cosmetic patients. Dermatol Ther. 2008 Jan-Feb; 21(1):47-53.
-
Lee CS, Accordino R, Howard J, Koo J. Psychopharmacology in dermatology. Dermatol Ther. 2008 Jan-Feb; 21(1):69-82.
-
Sah DE, Koo J, Price VH. Trichotillomania. Dermatol Ther. 2008 Jan-Feb; 21(1):13-21.
-
Koo JY. Relevance of the COBRA trial in current psoriasis practice. Cutis. 2007 Nov; 80(5 Suppl):4-11.
-
Maskatia ZK, Koo J. Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporine. J Drugs Dermatol. 2007 Sep; 6(9):941-4.
-
Zakarian K, Nguyen A, Letsinger J, Koo J. Excimer laser for psoriasis: a review of theories regarding enhanced efficacy over traditional UVB phototherapy. J Drugs Dermatol. 2007 Aug; 6(8):794-8.
-
McNeill AM, Koo JY. "Unknown Risks" of non-steroid topical medications for atopic dermatitis. Int J Dermatol. 2007 Jun; 46(6):656-8.
-
Fife DJ, Waller JM, Jeffes EW, Koo JY. Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles. Dermatol Online J. 2007; 13(2):4.
-
Leon A, Nguyen A, Letsinger J, Koo J. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options. Expert Opin Pharmacother. 2007 Apr; 8(5):617-32.
-
Koo JY. Using topical multimodal strategies for patients with psoriasis. Cutis. 2007 Jan; 79(1 Suppl 2):11-7.
-
Xu LY, Koo J. Predictive value of phenotypic variables for skin cancer: risk assessment beyond skin typing. Int J Dermatol. 2006 Nov; 45(11):1275-83.
-
Murase JE, Wu JJ, Koo J. Morgellons disease: a rapport-enhancing term for delusions of parasitosis. J Am Acad Dermatol. 2006 Nov; 55(5):913-4.
-
Hebert AA, Koo J, Fowler J, Berman B, Rosenberg C, Levitt J. Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis. Cutis. 2006 Nov; 78(5):357-63.
-
Koo J, Blum RR, Lebwohl M. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. J Am Acad Dermatol. 2006 Oct; 55(4):637-41.
-
Koo JY, Bagel J, Sweetser MT, Ticho BS. Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: results from an open-label, multicenter study. J Drugs Dermatol. 2006 Jul-Aug; 5(7):623-8.
-
Ting PT, Koo JY. Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients. Int J Dermatol. 2006 Jun; 45(6):689-92.
-
O'Brien M, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol. 2006 May; 5(5):426-32.
-
Navi D, Koo J. Safety update on commonly used psychotropic medications in dermatology. J Drugs Dermatol. 2006 Feb; 5(2):109-15.
-
Golda N, Benham SM, Koo J. Rebound of psoriasis during treatment with efalizumab. J Drugs Dermatol. 2006 Jan; 5(1):63-5.
-
Murase JE, Lee EE, Koo J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int J Dermatol. 2005 Dec; 44(12):1016-21.
-
Koo JY. New developments in topical sequential therapy for psoriasis. Skin Therapy Lett. 2005 Nov; 10(9):1-4.
-
Behnam SM, Behnam SE, Koo JY. TNF-alpha inhibitors and congestive heart failure. Skinmed. 2005 Nov-Dec; 4(6):363-8.
-
Starling J, Koo J. Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects. J Drugs Dermatol. 2005 Nov-Dec; 4(6):690-6.
-
Lee CS, Koo J. Psychopharmacologic therapies in dermatology: an update. Dermatol Clin. 2005 Oct; 23(4):735-44.
-
Ortonne JP, Khemis A, Koo JY, Choi J. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis. J Eur Acad Dermatol Venereol. 2005 Sep; 19(5):556-63.
-
Behnam SM, Behnam SE, Koo JY. Alcohol as a risk factor for plaque-type psoriasis. Cutis. 2005 Sep; 76(3):181-5.
-
Koo JY, Fleischer AB, Abramovits W, Pariser DM, McCall CO, Horn TD, Gottlieb AB, Jaracz E, Rico MJ. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. J Am Acad Dermatol. 2005 Aug; 53(2 Suppl 2):S195-205.
-
Lee CS, Koo J. A review of acitretin, a systemic retinoid for the treatment of psoriasis. Expert Opin Pharmacother. 2005 Aug; 6(10):1725-34.
-
Krishnan A, Koo J. Psyche, opioids, and itch: therapeutic consequences. Dermatol Ther. 2005 Jul-Aug; 18(4):314-22.
-
Feldman SR, Koo JY, Menter A, Bagel J. Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol. 2005 Jul; 53(1):101-7.
-
Khera P, Koo JY. A review of the chemopreventive and chemotherapeutic effects of topical and oral retinoids for both cutaneous and internal neoplasms. J Drugs Dermatol. 2005 Jul-Aug; 4(4):432-46.
-
Feldman S, Behnam SM, Behnam SE, Koo JY. Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol. 2005 Jul; 53(1 Suppl 1):S78-85.
-
Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol. 2005 May; 44(5):355-60.
-
Lee M, Koo J. Rosacea, light, and phototherapy. J Drugs Dermatol. 2005 May-Jun; 4(3):326-9.
-
Behnam SM, Behnam SE, Koo JY. Smoking and psoriasis. Skinmed. 2005 May-Jun; 4(3):174-6.
-
Lee E, Koo J. Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. J Dermatolog Treat. 2005 Apr; 16(2):102-7.
-
Koo J, Khera P. Update on the mechanisms and efficacy of biological therapies for psoriasis. J Dermatol Sci. 2005 May; 38(2):75-87.
-
Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: traditional therapy. Ann Rheum Dis. 2005 Mar; 64 Suppl 2:ii83-6.
-
Behnam SM, Behnam SE, Koo JY. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use. J Drugs Dermatol. 2005 Mar-Apr; 4(2):189-94.
-
Madkan VK, Bandow GD, Koo JY. Resolution of pruritus secondary to polycythemia vera in a patient treated with narrow-band ultraviolet B phototherapy. J Dermatolog Treat. 2005 Feb; 16(1):56-7.
-
Gordon KB, Feldman SR, Koo JY, Menter A, Rolstad T, Krueger G. Definitions of measures of effect duration for psoriasis treatments. Arch Dermatol. 2005 Jan; 141(1):82-4.
-
Mukhtar R, Choi J, Koo JY. Quality-of-life issues in psoriasis. Dermatol Clin. 2004 Oct; 22(4):389-95, viii.
-
Bandow GD, Koo JY. Narrow-band ultraviolet B radiation: a review of the current literature. Int J Dermatol. 2004 Aug; 43(8):555-61.
-
Koo J, Lee E, Lee CS, Lebwohl M. Psoriasis. J Am Acad Dermatol. 2004 Apr; 50(4):613-22.
-
Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004 Mar; 50(3):416-30.
-
Yang A, Koo JY. Non-psychotic uses for anti-psychotics. J Drugs Dermatol. 2004 Mar-Apr; 3(2):162-8.
-
Feldman SR, Menter A, Koo JY. Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis. Br J Dermatol. 2004 Feb; 150(2):317-26.
-
Lee E, Koo J. Single-center retrospective study of long-term use of low-dose acitretin (Soriatane) for psoriasis. J Dermatolog Treat. 2004 Jan; 15(1):8-13.
-
Lorenzo CR, Koo J. Pimozide in dermatologic practice: a comprehensive review. Am J Clin Dermatol. 2004; 5(5):339-49.
-
Koo J, Behnam SE, Behnam SM. The efficacy of topical tazarotene monotherapy and combination therapies in psoriasis. Expert Opin Pharmacother. 2003 Dec; 4(12):2347-54.
-
Shikiar R, Bresnahan BW, Stone SP, Thompson C, Koo J, Revicki DA. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes. 2003; 1:53.
-
Lee CS, Koo J. Psychocutaneous drug therapy. Semin Cutan Med Surg. 2003 Sep; 22(3):222-33.
-
Choi J, Koo JY. Quality of life issues in psoriasis. J Am Acad Dermatol. 2003 Aug; 49(2 Suppl):S57-61.
-
Koo J. How do you foster medication adherence for better acne vulgaris management? Skinmed. 2003 Jul-Aug; 2(4):229-33.
-
Weinstein GD, Koo JY, Krueger GG, Lebwohl MG, Lowe NJ, Menter MA, Lew-Kaya DA, Sefton J, Gibson JR, Walker PS. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol. 2003 May; 48(5):760-7.
-
Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, Eichenfield LF, Ferrandiz C, Giannetti A, Hanifin J, Koo JY, Leung D, Lynde C, Ring J, Ruiz-Maldonado R, Saurat JH. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003 May; 148 Suppl 63:3-10.
-
Lebwohl M, Menter A, Koo J, Feldman S. Case studies in severe psoriasis: A clinical strategy. J Dermatolog Treat. 2003; 14 Suppl 2:26-46.
-
Koo J, Desai R. Traditional Chinese medicine in dermatology. Dermatol Ther. 2003; 16(2):98-105.
-
Koo J. Vitamin D and scalp psoriasis. Cutis. 2002 Nov; 70(5 Suppl):21-4.
-
Koo JY, Ng TC. Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications. Clin Dermatol. 2002 Sep-Oct; 20(5):582-94.
-
Zackheim HS, Koo J, LeBoit PE, McCalmont TH, Bowman PH, Kashani-Sabet M, Jones C, Zehnder J. Psoriasiform mycosis fungoides with fatal outcome after treatment with cyclosporine. J Am Acad Dermatol. 2002 Jul; 47(1):155-7.
-
Bowman PH, Maloney JE, Koo JY. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study. J Am Acad Dermatol. 2002 Jun; 46(6):907-13.
-
Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol. 2002 May; 41(5):269-74.
-
Koo J, Lebwohl A. Psycho dermatology: the mind and skin connection. Am Fam Physician. 2001 Dec 1; 64(11):1873-8.
-
Lebwohl M, Drake L, Menter A, Koo J, Gottlieb AB, Zanolli M, Young M, McClelland P. Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol. 2001 Oct; 45(4):544-53.
-
Bowman PH, Koo JY. Clearance can be a realistic expectation of psoriasis treatment. J Am Acad Dermatol. 2001 Sep; 45(3):476.
-
Koo JY, Martin D. Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis. Int J Dermatol. 2001 Mar; 40(3):210-2.
-
Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001 Mar; 137(3):280-4.
-
Koo J, Lee CS. Delusions of parasitosis. A dermatologist's guide to diagnosis and treatment. Am J Clin Dermatol. 2001; 2(5):285-90.
-
Strauss JS, Gottlieb AB, Jones T, Koo JY, Leyden JJ, Lucky A, Pappas AA, McLane J, Leach EE. Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial. J Am Acad Dermatol. 2000 Nov; 43(5 Pt 1):777-84.
-
Koo JY, Do JH, Lee CS. Psychodermatology. J Am Acad Dermatol. 2000 Nov; 43(5 Pt 1):848-53.
-
Koo JY, Lowe NJ, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, Gibson JR. Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol. 2000 Nov; 43(5 Pt 1):821-8.
-
Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol. 2000 Aug; 43(2 Pt 1):281-5.
-
Koo J, Liao W. Update on psoriasis therapy: a perspective from the USA. Keio J Med. 2000 Mar; 49(1):20-5.
-
Koo JY. Current consensus and update on psoriasis therapy: a perspective from the U.S. J Dermatol. 1999 Nov; 26(11):723-33.
-
Koo J. Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results. J Am Acad Dermatol. 1999 Sep; 41(3 Pt 2):S25-8.
-
Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol. 1999 Jul; 41(1):51-9.
-
Lim HW, Anderson TF, Douglass M, Koo J, Lebwohl M, Morison W, Taylor C, Zanolli M. Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis. Arch Dermatol. 1999 Jun; 135(6):717-8.
-
Koo J, Arain S. Traditional Chinese medicine in dermatology. Clin Dermatol. 1999 Jan-Feb; 17(1):21-7.
-
Koo J, Arain S. Traditional Chinese medicine for the treatment of dermatologic disorders. Arch Dermatol. 1998 Nov; 134(11):1388-93.
-
Koo JY. Tazarotene in combination with phototherapy. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 2):S144-8.
-
Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K, Shupack J, Weinstein G. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol. 1998 Sep; 39(3):464-75.
-
Koo J. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group. Br J Dermatol. 1998 Jul; 139(1):88-95.
-
Koo J, Cuffie CA, Tanner DJ, Bressinck R, Cornell RC, DeVillez RL, Edwards L, Breneman DL, Piacquadio DJ, Guzzo CA, Monroe EW. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study. Clin Ther. 1998 Mar-Apr; 20(2):283-91.
-
Koo JY. How and where tazarotene might fit into the current therapeutic armamentarium: an expert opinion. Cutis. 1998 Feb; 61(2 Suppl):36-7.
-
Koo J. Neoral in psoriasis therapy: toward a new perspective. Int J Dermatol. 1997 Dec; 36 Suppl 1:25-9.
-
Koo J. Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review. J Am Acad Dermatol. 1997 Sep; 37(3 Pt 2):S59-61.
-
Shupack J, Abel E, Bauer E, Brown M, Drake L, Freinkel R, Guzzo C, Koo J, Levine N, Lowe N, McDonald C, Margolis D, Stiller M, Wintroub B, Bainbridge C, Evans S, Hilss S, Mietlowski W, Winslow C, Birnbaum JE. Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol. 1997 Mar; 36(3 Pt 1):423-32.
-
Koo J, Nguyen Q, Gambla C. Advances in psoriasis therapy. Adv Dermatol. 1997; 12:47-72; discussion 73.
-
Koo J, Gambla C. Psychopharmacology for dermatologic patients. Dermatol Clin. 1996 Jul; 14(3):509-23.
-
Koo J, Gambla C. Cutaneous sensory disorder. Dermatol Clin. 1996 Jul; 14(3):497-502.
-
Koo J, Gambla C, Fried R. Pseudopsychodermatologic disease. Dermatol Clin. 1996 Jul; 14(3):525-30.
-
Koo J, Gambla C. Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis. General discussion and case illustrations. Dermatol Clin. 1996 Jul; 14(3):429-38.
-
Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996 Jul; 14(3):485-96.
-
Badger J, Berger TG, Gambla C, Koo JY. HIV and psoriasis. Clin Rev Allergy Immunol. 1996-1997 Winter; 14(4):417-31.
-
Lebwohl M, Abel E, Zanolli M, Koo J, Drake L. Topical therapy for psoriasis. Int J Dermatol. 1995 Oct; 34(10):673-84.
-
Koo J, Lee J. Cyclosporine: what clinicians need to know. Dermatol Clin. 1995 Oct; 13(4):897-907.
-
Koo J. The psychosocial impact of acne: patients' perceptions. J Am Acad Dermatol. 1995 May; 32(5 Pt 3):S26-30.
-
Koo JY, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol. 1994 Dec; 33(12):849-50.
-
Maurer TA, Winter ME, Koo J, Berger TG. Refractory hypoglycemia: a complication of topical salicylate therapy. Arch Dermatol. 1994 Nov; 130(11):1455-7.
-
Hallman CP, Koo JY, Omohundro C, Lee J. Plasma levels of 8-methoxypsoralen after topical paint PUVA on nonpalmoplantar psoriatic skin. J Am Acad Dermatol. 1994 Aug; 31(2 Pt 1):273-5.
-
Bircher AJ, Koo JY, Frieden IJ, Berger TG. Angiodysplastic syndrome with capillary and venous malformation associated with soft tissue hypotrophy. Dermatology. 1994; 189(3):292-6.
-
Pham CT, Koo JY. Plasma levels of 8-methoxypsoralen after topical paint PUVA. J Am Acad Dermatol. 1993 Mar; 28(3):460-6.
-
Koo JY. Psychotropic agents in dermatology. Dermatol Clin. 1993 Jan; 11(1):215-24.
-
Koo J. Psoriasis symposium. Phototherapy. Semin Dermatol. 1992 Dec; 11(4 Suppl 1):11-6.
-
Koo JY. The use of psychotropic medications in clinical dermatology. Dermatol Clin. 1992 Jul; 10(3):641-5.
-
Koo JY, Kadonaga JN, Wintroub BV, Lozada-Nur FI. The development of B-cell lymphoma in a patient with psoriasis treated with cyclosporine. J Am Acad Dermatol. 1992 May; 26(5 Pt 2):836-40.
-
Koo JY, Pham CT. Psychodermatology. Practical guidelines on pharmacotherapy. Arch Dermatol. 1992 Mar; 128(3):381-8.
-
Shellow WV, Edwards JE, Koo JY. Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol. 1992 Mar; 31(3):186-9.
-
Koo JY, Smith LL. Psychologic aspects of acne. Pediatr Dermatol. 1991 Sep; 8(3):185-8.
-
Koo JY, Smith LL. Obsessive-compulsive disorders in the pediatric dermatology practice. Pediatr Dermatol. 1991 Jun; 8(2):107-13.
-
Jang TW, Koo JY, Park BC. Relationship between T-lymphocyte subsets and suppressor cell activity in patients with chronic active hepatitis B. Korean J Intern Med. 1989 Jan; 4(1):41-7.
-
Tam PK, Saing H, Koo J, Wong J, Ong GB. Pyloric function five to eleven years after Ramstedt's pyloromyotomy. J Pediatr Surg. 1985 Jun; 20(3):236-9.
-
Koo J, Fung K, Siu KF, Lee NW, Lett Z, Ho J, Wong J, Ong GB. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma. Cancer. 1983 Nov 15; 52(10):1952-6.
-
Koo J, Lam SK, Chan P, Lee NW, Lam P, Wong J, Ong GB. Proximal gastric vagotomy, truncal vagotomy with drainage, and truncal vagotomy with antrectomy for chronic duodenal ulcer. A prospective, randomized controlled trial. Ann Surg. 1983 Mar; 197(3):265-71.
-
Boey J, Lee NW, Koo J, Lam PH, Wong J, Ong GB. Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial. Ann Surg. 1982 Sep; 196(3):338-44.
-
Koo J, Ho J, Wong J, Ong GB. Mucoepidermoid carcinoma of the bile duct. Ann Surg. 1982 Aug; 196(2):140-8.
-
Choi TK, Koo J, Wong J, Ong GB. Survival after surgery for advanced carcinoma of the stomach other than the cardia. Am J Surg. 1982 Jun; 143(6):748-50.
-
Koo J, Ho J, Lam SK, Wong J, Ong GB. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat. Gastroenterology. 1982 May; 82(5 Pt 1):864-70.
-
Koo J, Wong J, Cheng FC, Ong GB. Carcinoma of the gallbladder. Br J Surg. 1981 Mar; 68(3):161-5.
|
John's Networks
Click the "See All" links for more information and interactive visualizations!
Related Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share similar concepts with this person. _
|
